nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylephrine—ADRA1D—polycystic ovary syndrome	0.372	0.412	CbGaD
Phenylephrine—ADRA1B—polycystic ovary syndrome	0.318	0.351	CbGaD
Phenylephrine—ADRA1A—polycystic ovary syndrome	0.214	0.237	CbGaD
Phenylephrine—Metaraminol—ADRA1A—polycystic ovary syndrome	0.00103	0.155	CrCbGaD
Phenylephrine—Orciprenaline—ADRB2—polycystic ovary syndrome	0.00068	0.102	CrCbGaD
Phenylephrine—Norepinephrine—ADRA1D—polycystic ovary syndrome	0.000484	0.0725	CrCbGaD
Phenylephrine—Isoprenaline—ADRB3—polycystic ovary syndrome	0.00047	0.0703	CrCbGaD
Phenylephrine—Terbutaline—ADRB2—polycystic ovary syndrome	0.000447	0.0669	CrCbGaD
Phenylephrine—Epinephrine—ADRA1D—polycystic ovary syndrome	0.00044	0.0658	CrCbGaD
Phenylephrine—Norepinephrine—ADRB3—polycystic ovary syndrome	0.000435	0.0651	CrCbGaD
Phenylephrine—Norepinephrine—ADRA1B—polycystic ovary syndrome	0.000413	0.0618	CrCbGaD
Phenylephrine—Epinephrine—ADRB3—polycystic ovary syndrome	0.000395	0.0591	CrCbGaD
Phenylephrine—Epinephrine—ADRA1B—polycystic ovary syndrome	0.000375	0.0561	CrCbGaD
Phenylephrine—Salbutamol—ADRB2—polycystic ovary syndrome	0.000332	0.0497	CrCbGaD
Phenylephrine—Norepinephrine—ADRA1A—polycystic ovary syndrome	0.000278	0.0416	CrCbGaD
Phenylephrine—Epinephrine—ADRA1A—polycystic ovary syndrome	0.000252	0.0378	CrCbGaD
Phenylephrine—Isoprenaline—ADRB2—polycystic ovary syndrome	0.000179	0.0267	CrCbGaD
Phenylephrine—Norepinephrine—ADRB2—polycystic ovary syndrome	0.000165	0.0248	CrCbGaD
Phenylephrine—Isoprenaline—CYP1A1—polycystic ovary syndrome	0.000153	0.0229	CrCbGaD
Phenylephrine—Epinephrine—ADRB2—polycystic ovary syndrome	0.00015	0.0225	CrCbGaD
Phenylephrine—ADRA1A—GPCR ligand binding—ADRB2—polycystic ovary syndrome	3.65e-05	0.000407	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—SCT—polycystic ovary syndrome	3.61e-05	0.000404	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	3.59e-05	0.000401	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PTGER3—polycystic ovary syndrome	3.58e-05	0.0004	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—LHCGR—polycystic ovary syndrome	3.58e-05	0.0004	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—SCT—polycystic ovary syndrome	3.53e-05	0.000395	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—ADRB3—polycystic ovary syndrome	3.46e-05	0.000387	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PDE3B—polycystic ovary syndrome	3.46e-05	0.000387	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	3.45e-05	0.000385	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	3.44e-05	0.000385	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—LHB—polycystic ovary syndrome	3.42e-05	0.000383	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—GNAS—polycystic ovary syndrome	3.38e-05	0.000378	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—GHRL—polycystic ovary syndrome	3.38e-05	0.000377	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	3.37e-05	0.000377	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	3.36e-05	0.000376	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—LHB—polycystic ovary syndrome	3.36e-05	0.000376	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—GNRH1—polycystic ovary syndrome	3.35e-05	0.000374	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PTAFR—polycystic ovary syndrome	3.34e-05	0.000374	CbGpPWpGaD
Phenylephrine—CYP1A2—Biological oxidations—CYP1A1—polycystic ovary syndrome	3.32e-05	0.000371	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—HSD3B2—polycystic ovary syndrome	3.29e-05	0.000367	CbGpPWpGaD
Phenylephrine—CYP1A2—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	3.27e-05	0.000366	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ADRA1D—polycystic ovary syndrome	3.25e-05	0.000363	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—SCT—polycystic ovary syndrome	3.21e-05	0.000358	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—AKR1C1—polycystic ovary syndrome	3.18e-05	0.000356	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PTGER3—polycystic ovary syndrome	3.18e-05	0.000355	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—LHCGR—polycystic ovary syndrome	3.18e-05	0.000355	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—FSHR—polycystic ovary syndrome	3.15e-05	0.000352	CbGpPWpGaD
Phenylephrine—MAOA—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	3.15e-05	0.000352	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—POMC—polycystic ovary syndrome	3.09e-05	0.000345	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—INHBB—polycystic ovary syndrome	3.08e-05	0.000344	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—GHRL—polycystic ovary syndrome	3.07e-05	0.000343	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	3.06e-05	0.000342	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	3.05e-05	0.000341	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	2.99e-05	0.000334	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PTAFR—polycystic ovary syndrome	2.97e-05	0.000332	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—RACGAP1—polycystic ovary syndrome	2.96e-05	0.000331	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—SULT2A1—polycystic ovary syndrome	2.93e-05	0.000327	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—NMNAT3—polycystic ovary syndrome	2.92e-05	0.000326	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—ADRA1A—polycystic ovary syndrome	2.88e-05	0.000322	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	2.88e-05	0.000322	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PDE3B—polycystic ovary syndrome	2.87e-05	0.000321	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—RRM2—polycystic ovary syndrome	2.84e-05	0.000317	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—FST—polycystic ovary syndrome	2.81e-05	0.000314	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	2.81e-05	0.000313	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—GHRL—polycystic ovary syndrome	2.8e-05	0.000313	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	2.79e-05	0.000312	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	2.79e-05	0.000311	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.78e-05	0.00031	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—LHB—polycystic ovary syndrome	2.74e-05	0.000307	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—YAP1—polycystic ovary syndrome	2.74e-05	0.000306	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—INHBB—polycystic ovary syndrome	2.73e-05	0.000305	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	2.72e-05	0.000304	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.68e-05	0.0003	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	2.67e-05	0.000298	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	2.67e-05	0.000298	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	2.64e-05	0.000295	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—NAMPT—polycystic ovary syndrome	2.63e-05	0.000294	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—FSHR—polycystic ovary syndrome	2.62e-05	0.000292	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.6e-05	0.00029	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—CYP11A1—polycystic ovary syndrome	2.6e-05	0.00029	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.59e-05	0.00029	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—SCT—polycystic ovary syndrome	2.57e-05	0.000287	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—POMC—polycystic ovary syndrome	2.56e-05	0.000286	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PDE3B—polycystic ovary syndrome	2.55e-05	0.000285	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—GHRL—polycystic ovary syndrome	2.54e-05	0.000284	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—ADRB2—polycystic ovary syndrome	2.54e-05	0.000284	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	2.49e-05	0.000278	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	2.48e-05	0.000277	CbGpPWpGaD
Phenylephrine—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	2.47e-05	0.000277	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—RACGAP1—polycystic ovary syndrome	2.46e-05	0.000275	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.45e-05	0.000274	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—AKR1C3—polycystic ovary syndrome	2.45e-05	0.000274	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	2.43e-05	0.000271	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—CYP17A1—polycystic ovary syndrome	2.41e-05	0.00027	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—FGF18—polycystic ovary syndrome	2.41e-05	0.000269	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ADRA1A—polycystic ovary syndrome	2.39e-05	0.000267	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—RBP4—polycystic ovary syndrome	2.39e-05	0.000267	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	2.38e-05	0.000266	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.35e-05	0.000263	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—FST—polycystic ovary syndrome	2.33e-05	0.000261	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—FSHR—polycystic ovary syndrome	2.32e-05	0.00026	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	2.32e-05	0.000259	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.3e-05	0.000257	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—LHB—polycystic ovary syndrome	2.28e-05	0.000254	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—POMC—polycystic ovary syndrome	2.28e-05	0.000254	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	2.27e-05	0.000253	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—GHRL—polycystic ovary syndrome	2.26e-05	0.000253	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—YAP1—polycystic ovary syndrome	2.23e-05	0.000249	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.23e-05	0.000249	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—GAB1—polycystic ovary syndrome	2.2e-05	0.000246	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	2.19e-05	0.000244	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.16e-05	0.000241	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.15e-05	0.00024	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	2.15e-05	0.00024	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—SCT—polycystic ovary syndrome	2.13e-05	0.000238	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	2.11e-05	0.000236	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	2.11e-05	0.000236	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—ADRB2—polycystic ovary syndrome	2.11e-05	0.000235	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—INSR—polycystic ovary syndrome	2.1e-05	0.000235	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—TH—polycystic ovary syndrome	2.09e-05	0.000233	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—FST—polycystic ovary syndrome	2.07e-05	0.000232	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	2.06e-05	0.00023	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.05e-05	0.000229	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.04e-05	0.000227	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—SLC2A4—polycystic ovary syndrome	2.03e-05	0.000227	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	2.03e-05	0.000227	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—LHB—polycystic ovary syndrome	2.02e-05	0.000226	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—FGF18—polycystic ovary syndrome	2e-05	0.000223	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2e-05	0.000223	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	2e-05	0.000223	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—RBP4—polycystic ovary syndrome	1.98e-05	0.000222	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—GNRH1—polycystic ovary syndrome	1.98e-05	0.000221	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	1.97e-05	0.000221	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.97e-05	0.00022	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—GNAS—polycystic ovary syndrome	1.95e-05	0.000218	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PGR—polycystic ovary syndrome	1.95e-05	0.000218	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	1.91e-05	0.000214	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	1.91e-05	0.000213	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—CYP19A1—polycystic ovary syndrome	1.91e-05	0.000213	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—SCT—polycystic ovary syndrome	1.9e-05	0.000212	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	1.87e-05	0.000209	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—YAP1—polycystic ovary syndrome	1.85e-05	0.000207	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—GAB1—polycystic ovary syndrome	1.83e-05	0.000204	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PLAT—polycystic ovary syndrome	1.81e-05	0.000202	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—GHRL—polycystic ovary syndrome	1.81e-05	0.000202	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	1.81e-05	0.000202	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—FGF18—polycystic ovary syndrome	1.78e-05	0.000199	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	1.77e-05	0.000198	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—RBP4—polycystic ovary syndrome	1.76e-05	0.000197	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	1.75e-05	0.000196	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—INSR—polycystic ovary syndrome	1.75e-05	0.000195	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.74e-05	0.000195	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—GNAS—polycystic ovary syndrome	1.73e-05	0.000194	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—ATF1—polycystic ovary syndrome	1.73e-05	0.000193	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—GNAS—polycystic ovary syndrome	1.7e-05	0.00019	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.68e-05	0.000188	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.68e-05	0.000187	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	1.68e-05	0.000187	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.66e-05	0.000185	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—YAP1—polycystic ovary syndrome	1.64e-05	0.000184	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.63e-05	0.000183	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—NCOR1—polycystic ovary syndrome	1.62e-05	0.000181	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—GAB1—polycystic ovary syndrome	1.62e-05	0.000181	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PGR—polycystic ovary syndrome	1.62e-05	0.000181	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	1.6e-05	0.000179	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NGFR—polycystic ovary syndrome	1.59e-05	0.000178	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—POMC—polycystic ovary syndrome	1.58e-05	0.000177	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	1.58e-05	0.000177	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PRL—polycystic ovary syndrome	1.58e-05	0.000177	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—INSR—polycystic ovary syndrome	1.55e-05	0.000173	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—CYP1A1—polycystic ovary syndrome	1.54e-05	0.000172	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.52e-05	0.00017	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—GHRL—polycystic ovary syndrome	1.5e-05	0.000168	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PLAT—polycystic ovary syndrome	1.5e-05	0.000168	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.5e-05	0.000168	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.47e-05	0.000165	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.45e-05	0.000162	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.45e-05	0.000162	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PGR—polycystic ovary syndrome	1.44e-05	0.00016	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—MTHFR—polycystic ovary syndrome	1.43e-05	0.00016	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ATF1—polycystic ovary syndrome	1.43e-05	0.00016	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	1.43e-05	0.000159	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.4e-05	0.000156	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.39e-05	0.000156	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—GNAS—polycystic ovary syndrome	1.39e-05	0.000155	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	1.36e-05	0.000152	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.34e-05	0.00015	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—GHRL—polycystic ovary syndrome	1.34e-05	0.000149	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PLAT—polycystic ovary syndrome	1.34e-05	0.000149	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.32e-05	0.000148	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NGFR—polycystic ovary syndrome	1.32e-05	0.000148	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—POMC—polycystic ovary syndrome	1.32e-05	0.000147	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PRL—polycystic ovary syndrome	1.31e-05	0.000147	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NRG1—polycystic ovary syndrome	1.3e-05	0.000145	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.29e-05	0.000144	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.27e-05	0.000142	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ATF1—polycystic ovary syndrome	1.27e-05	0.000142	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.26e-05	0.000141	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.24e-05	0.000139	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.24e-05	0.000139	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	1.24e-05	0.000139	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.24e-05	0.000138	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	1.21e-05	0.000135	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NGFR—polycystic ovary syndrome	1.18e-05	0.000131	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	1.17e-05	0.000131	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—POMC—polycystic ovary syndrome	1.17e-05	0.000131	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PRL—polycystic ovary syndrome	1.16e-05	0.00013	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PPARG—polycystic ovary syndrome	1.16e-05	0.00013	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—GNAS—polycystic ovary syndrome	1.15e-05	0.000129	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—POMC—polycystic ovary syndrome	1.15e-05	0.000128	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—INS—polycystic ovary syndrome	1.14e-05	0.000128	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.12e-05	0.000125	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IRS2—polycystic ovary syndrome	1.11e-05	0.000124	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.11e-05	0.000123	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.1e-05	0.000123	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—LEP—polycystic ovary syndrome	1.09e-05	0.000122	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	1.08e-05	0.000121	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NRG1—polycystic ovary syndrome	1.08e-05	0.000121	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	1.05e-05	0.000117	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—GNAS—polycystic ovary syndrome	1.02e-05	0.000115	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	1.01e-05	0.000113	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.76e-06	0.000109	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IRS1—polycystic ovary syndrome	9.72e-06	0.000109	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	9.69e-06	0.000108	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	9.64e-06	0.000108	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NRG1—polycystic ovary syndrome	9.58e-06	0.000107	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	9.57e-06	0.000107	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	9.5e-06	0.000106	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—POMC—polycystic ovary syndrome	9.36e-06	0.000105	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—INS—polycystic ovary syndrome	9.31e-06	0.000104	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IRS2—polycystic ovary syndrome	9.24e-06	0.000103	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—LEP—polycystic ovary syndrome	9.04e-06	0.000101	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	9.04e-06	0.000101	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IGF1—polycystic ovary syndrome	9e-06	0.000101	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—AKT2—polycystic ovary syndrome	9e-06	0.000101	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	8.9e-06	9.94e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.55e-06	9.55e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IRS2—polycystic ovary syndrome	8.21e-06	9.17e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IRS1—polycystic ovary syndrome	8.07e-06	9.01e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—LEP—polycystic ovary syndrome	8.03e-06	8.97e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—POMC—polycystic ovary syndrome	7.77e-06	8.68e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—INS—polycystic ovary syndrome	7.73e-06	8.63e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—TH—polycystic ovary syndrome	7.7e-06	8.6e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	7.49e-06	8.37e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IGF1—polycystic ovary syndrome	7.47e-06	8.35e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—AKT2—polycystic ovary syndrome	7.47e-06	8.34e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IRS1—polycystic ovary syndrome	7.17e-06	8.01e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.1e-06	7.93e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	7.04e-06	7.87e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—POMC—polycystic ovary syndrome	6.9e-06	7.71e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—IL6—polycystic ovary syndrome	6.88e-06	7.69e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—INS—polycystic ovary syndrome	6.86e-06	7.67e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IGF1—polycystic ovary syndrome	6.64e-06	7.42e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—AKT2—polycystic ovary syndrome	6.63e-06	7.41e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.3e-06	7.04e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	6.29e-06	7.02e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	5.99e-06	6.69e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.88e-06	6.57e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—IL6—polycystic ovary syndrome	5.71e-06	6.38e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	5.68e-06	6.34e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	5.29e-06	5.91e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—IL6—polycystic ovary syndrome	5.08e-06	5.67e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.88e-06	5.45e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.34e-06	4.84e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	4.29e-06	4.8e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	4.23e-06	4.73e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—INS—polycystic ovary syndrome	4.21e-06	4.7e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IL6—polycystic ovary syndrome	4.07e-06	4.54e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IL6—polycystic ovary syndrome	3.38e-06	3.77e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—urine—polycystic ovary syndrome	3.04e-06	0.207	CbGeAlD
Phenylephrine—ADRA1A—Signaling Pathways—IL6—polycystic ovary syndrome	3e-06	3.35e-05	CbGpPWpGaD
Phenylephrine—MAOA—embryo—polycystic ovary syndrome	1.18e-06	0.0804	CbGeAlD
Phenylephrine—ADRA1D—endocrine gland—polycystic ovary syndrome	1.06e-06	0.0724	CbGeAlD
Phenylephrine—MAOA—adrenal cortex—polycystic ovary syndrome	9.64e-07	0.0659	CbGeAlD
Phenylephrine—MAOA—endometrium—polycystic ovary syndrome	8.61e-07	0.0588	CbGeAlD
Phenylephrine—MAOA—uterus—polycystic ovary syndrome	7.93e-07	0.0542	CbGeAlD
Phenylephrine—ADRA1A—adipose tissue—polycystic ovary syndrome	7.83e-07	0.0535	CbGeAlD
Phenylephrine—MAOA—pituitary gland—polycystic ovary syndrome	7.79e-07	0.0532	CbGeAlD
Phenylephrine—MAOA—adipose tissue—polycystic ovary syndrome	7.76e-07	0.053	CbGeAlD
Phenylephrine—ADRA1A—adrenal gland—polycystic ovary syndrome	7.02e-07	0.048	CbGeAlD
Phenylephrine—MAOA—adrenal gland—polycystic ovary syndrome	6.96e-07	0.0476	CbGeAlD
Phenylephrine—MAOA—female gonad—polycystic ovary syndrome	6.49e-07	0.0443	CbGeAlD
Phenylephrine—MAOA—vagina—polycystic ovary syndrome	6.45e-07	0.0441	CbGeAlD
Phenylephrine—ADRA1A—endocrine gland—polycystic ovary syndrome	6.09e-07	0.0416	CbGeAlD
Phenylephrine—MAOA—endocrine gland—polycystic ovary syndrome	6.03e-07	0.0412	CbGeAlD
Phenylephrine—CYP1A2—endocrine gland—polycystic ovary syndrome	5.03e-07	0.0344	CbGeAlD
